中华结核和呼吸杂志
中華結覈和呼吸雜誌
중화결핵화호흡잡지
Chinese Journal of Tuberculosis and Respiratory Diseases
2014年
6期
406-410
,共5页
肺炎%血液凝固障碍%预后
肺炎%血液凝固障礙%預後
폐염%혈액응고장애%예후
Pneumonia%Blood coagulation disorders%Prognosis
目的 探讨社区获得性肺炎(CAP)凝血功能异常与预后的相关性.方法 回顾性分析厦门大学附属第一医院呼吸科2010年6月至2011年5月收治的385例成人CAP患者凝血酶原时间(PT)、活化的部分凝血活酶时间(APTT)、纤维蛋白原(Fib)、凝血酶时间(TT)、血小板计数(PLT)及D-二聚体等凝血指标,观察其在不同预后组患者间的差异.入组患者同时计算肺炎严重度指数(PSI)并评估病情.按PSI及是否合并呼吸衰竭及出院时转归将385例分为低危组、中高危组、呼吸衰竭组、无呼吸衰竭组、生存组和死亡组.结果 中高危CAP患者PT、TT、D-二聚体测定值分别为(15.1±1.4)s、(16.0±1.8)s和(7.5±8.3) mg/L,均显著高于低危患者[(14.5±0.9)s、(15.4±1.2)s及(1.6±2.0)mg/L],差异均具有统计学意义(P<0.001),PLT、APTT、Fib差异无统计学意义(均P >0.05).中高危CAP患者和低危患者PLT、PT、D-二聚体异常率分别为30%(45/148)和20%(47/237)、18% (26/148)和5% (13/237)、99%(146/148)和85% (202/237),差异有统计学意义(x2值分别为5.602、14.609及23.442,均P<0.05),TT、APTT及Fib比较差异无统计学意义(P>0.05).D-二聚体与PSI存在等级相关性(r=0.798,P<0.001),血小板计数与PSI无关(x2=6.040,P >0.05).合并呼吸衰竭的CAP患者D-二聚体为(10.0±9.9)mg/L,高于无呼吸衰竭者的(2.4±3.6) mg/L,差异有统计学意义(P<0.001),血小板计数比较差异无统计学意义(x2=3.457,P>0.05).死亡CAP患者的D-二聚体为(14.0±8.8) mg/L,高于生存患者的(2.8±4.6)mg/L,差异有统计学意义(P<0.001),血小板计数比较差异有统计学意义(x2=4.909,P<0.05).使用ROC曲线分析D-二聚体、PSI及血小板计数对CAP患者病死率的独立预测能力,三者曲线下面积分别为0.962、0.906和0.583,D-二聚体及PSI预测死亡的准确性高(P<0.001),D-二聚体的敏感性优于特异性,血小板计数预测病死率准确性欠佳(P>0.05).结论 CAP患者血浆D-二聚体显著升高,且与病情严重程度及病死率呈正相关,D-二聚体可作为CAP预后评估的良好指标之一.
目的 探討社區穫得性肺炎(CAP)凝血功能異常與預後的相關性.方法 迴顧性分析廈門大學附屬第一醫院呼吸科2010年6月至2011年5月收治的385例成人CAP患者凝血酶原時間(PT)、活化的部分凝血活酶時間(APTT)、纖維蛋白原(Fib)、凝血酶時間(TT)、血小闆計數(PLT)及D-二聚體等凝血指標,觀察其在不同預後組患者間的差異.入組患者同時計算肺炎嚴重度指數(PSI)併評估病情.按PSI及是否閤併呼吸衰竭及齣院時轉歸將385例分為低危組、中高危組、呼吸衰竭組、無呼吸衰竭組、生存組和死亡組.結果 中高危CAP患者PT、TT、D-二聚體測定值分彆為(15.1±1.4)s、(16.0±1.8)s和(7.5±8.3) mg/L,均顯著高于低危患者[(14.5±0.9)s、(15.4±1.2)s及(1.6±2.0)mg/L],差異均具有統計學意義(P<0.001),PLT、APTT、Fib差異無統計學意義(均P >0.05).中高危CAP患者和低危患者PLT、PT、D-二聚體異常率分彆為30%(45/148)和20%(47/237)、18% (26/148)和5% (13/237)、99%(146/148)和85% (202/237),差異有統計學意義(x2值分彆為5.602、14.609及23.442,均P<0.05),TT、APTT及Fib比較差異無統計學意義(P>0.05).D-二聚體與PSI存在等級相關性(r=0.798,P<0.001),血小闆計數與PSI無關(x2=6.040,P >0.05).閤併呼吸衰竭的CAP患者D-二聚體為(10.0±9.9)mg/L,高于無呼吸衰竭者的(2.4±3.6) mg/L,差異有統計學意義(P<0.001),血小闆計數比較差異無統計學意義(x2=3.457,P>0.05).死亡CAP患者的D-二聚體為(14.0±8.8) mg/L,高于生存患者的(2.8±4.6)mg/L,差異有統計學意義(P<0.001),血小闆計數比較差異有統計學意義(x2=4.909,P<0.05).使用ROC麯線分析D-二聚體、PSI及血小闆計數對CAP患者病死率的獨立預測能力,三者麯線下麵積分彆為0.962、0.906和0.583,D-二聚體及PSI預測死亡的準確性高(P<0.001),D-二聚體的敏感性優于特異性,血小闆計數預測病死率準確性欠佳(P>0.05).結論 CAP患者血漿D-二聚體顯著升高,且與病情嚴重程度及病死率呈正相關,D-二聚體可作為CAP預後評估的良好指標之一.
목적 탐토사구획득성폐염(CAP)응혈공능이상여예후적상관성.방법 회고성분석하문대학부속제일의원호흡과2010년6월지2011년5월수치적385례성인CAP환자응혈매원시간(PT)、활화적부분응혈활매시간(APTT)、섬유단백원(Fib)、응혈매시간(TT)、혈소판계수(PLT)급D-이취체등응혈지표,관찰기재불동예후조환자간적차이.입조환자동시계산폐염엄중도지수(PSI)병평고병정.안PSI급시부합병호흡쇠갈급출원시전귀장385례분위저위조、중고위조、호흡쇠갈조、무호흡쇠갈조、생존조화사망조.결과 중고위CAP환자PT、TT、D-이취체측정치분별위(15.1±1.4)s、(16.0±1.8)s화(7.5±8.3) mg/L,균현저고우저위환자[(14.5±0.9)s、(15.4±1.2)s급(1.6±2.0)mg/L],차이균구유통계학의의(P<0.001),PLT、APTT、Fib차이무통계학의의(균P >0.05).중고위CAP환자화저위환자PLT、PT、D-이취체이상솔분별위30%(45/148)화20%(47/237)、18% (26/148)화5% (13/237)、99%(146/148)화85% (202/237),차이유통계학의의(x2치분별위5.602、14.609급23.442,균P<0.05),TT、APTT급Fib비교차이무통계학의의(P>0.05).D-이취체여PSI존재등급상관성(r=0.798,P<0.001),혈소판계수여PSI무관(x2=6.040,P >0.05).합병호흡쇠갈적CAP환자D-이취체위(10.0±9.9)mg/L,고우무호흡쇠갈자적(2.4±3.6) mg/L,차이유통계학의의(P<0.001),혈소판계수비교차이무통계학의의(x2=3.457,P>0.05).사망CAP환자적D-이취체위(14.0±8.8) mg/L,고우생존환자적(2.8±4.6)mg/L,차이유통계학의의(P<0.001),혈소판계수비교차이유통계학의의(x2=4.909,P<0.05).사용ROC곡선분석D-이취체、PSI급혈소판계수대CAP환자병사솔적독립예측능력,삼자곡선하면적분별위0.962、0.906화0.583,D-이취체급PSI예측사망적준학성고(P<0.001),D-이취체적민감성우우특이성,혈소판계수예측병사솔준학성흠가(P>0.05).결론 CAP환자혈장D-이취체현저승고,차여병정엄중정도급병사솔정정상관,D-이취체가작위CAP예후평고적량호지표지일.
Objective To explore and evaluate the predictive value of coagulopathy in patients with community-acquired pneumonia (CAP) Methods A retrospective study was performed by investigating the prothrombin time (PT),activated partial thromboplastin time (APTT),plasma fibrinogen (FIB),thrombin time(TT),platelets (PLT),and D-dimer in 385 patients with CAP,who were admitted to the Respiratory Medical Department of the First Affiliated Hospital of Xiamen University from June,2010 to May,2011.The differences of the aforementioned results in patients with different prognostic risks were compared and analyzed.The Pneumonia Severity Index (PSI) was calculated to assess the severity.Results The serum levels of PT,TT and D-dimer in high-risk patients with CAP were (15.1 ± 1.4) s,(16.0 ± 1.8) s,(7.5 ± 8.3) mg/L,respectively.They were all increased compared with those in the low-risk group (14.5 ± 0.9) s,(15.4 ± 1.2) s,(1.6 ± 2.0) mg/L] ; the differences being statistically significant (P < 0.001),while PLT,APTT,and FIB were not statistically different (P > 0.05).The difference of the abnormal rate of PLT,PT,and D-dimer in high-risk group and the low-risk group were 30% (45/148) and 20% (47/237),18% (26/148) and 5% (13/237),99% (146/148) and 85% (202/237),respectively,the differences being statistically significant (x2value were 5.602,14.609,23.442,respectively,P < 0.05),while TT,APTT,FIB were not (P > 0.05).Rank correlation existed between D-dimer and PSI (r =0.798,P <0.001),while there was no correlation between PLT and PSI(x2 =6.040,P > 0.05).D-dimer in patients with respiratory failure was (10.0 ± 9.9) mg/L,which was significantly increased compared with that in patients without respiratory failure (2.4 ± 3.6) mg/L,P < 0.001,and there was no significant difference in PLT (x2 =3.457,P > 0.05).D-dimer was significantly higher in patients who died of pneumonia as compared to those who survived [(14.0 ± 8.8) mg/L,(2.8 ± 4.6) mg/L,P < 0.001],and there was a significant difference in PLT (x2 =4.909,P < 0.05).The area under the receiver operator characteristic curve (ROC) of D-dimer,PSI and PLT were 0.962,0.906,0.583,respectively.Concerning the predictive value of mortality,both D-dimer and PSI showed ideal predictive accuracy (P < 0.001).The sensitivity of D-dimer was superior to its specificity.PLT showed poor predictive value for mortality.Conclusions Ddimer was significantly higher in patients with CAP.D-dimer level was positively correlated with severity and mortality.D-dimer could be a good biomarker to assess the severity and mortality of patients with CAP.